SNY

赛诺菲安万特
NASDAQ

实时行情|Nasdaq Last Sale

50.85
+0.10
+0.20%
盘后: 51.20 +0.35 +0.69% 18:58 02/21 EST
开盘
50.29
昨收
50.75
最高
50.88
最低
50.11
成交量
172.27万
成交额
--
52周最高
51.84
52周最低
40.00
市值
1,271.27亿
市盈率(TTM)
39.06
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测SNY价格均价为56.88,最高价位61.00,最低价为53.00。

EPS

SNY 新闻

更多
  • A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
  • MotleyFool.com · 7小时前
  • Oscar Health Cuts Co-Pays on About 100 Drugs to $3
  • MotleyFool.com · 7小时前
  • Investors Scrambled to Buy This Biotech IPO
  • MotleyFool.com · 9小时前
  • Pharma Stock Roundup: AZN Reports Q4 Results, NVS, PFE Drugs Get EU Approval
  • Zacks · 10小时前

所属板块

制药
+0.60%
制药与医学研究
+0.55%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

SNY 简况

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.
展开

微牛提供Sanofi SA (ADR)(NASDAQ-SNY)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的SNY股票新闻,以帮助您做出投资决策。